250,000 manufacturing capability is certainly a huge plus here along with the mobility and accuracy of the tests. Even allowing for ncyt test this market is massive for GDR let’s hope it follows the same trajectory.
Definitely looks like it's moving now as you say with NCYT connection could do very well. 3 on the bid at 18 1 on the offer 18.5 L2 looking strong for a change.
We need to take advantage of these drops as it will come back stronger into the afternoon. Like someone said a long weekend lots of press coverage across a lots of COVID-19 stocks.
Just added on the dip also take look at ODX another company commissioned by the government to develop an Antibody test, up today but still under the radar. Gla